Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2004
05/21/2004WO2004042030A2 Displacement sandwich immuno-pcr
05/21/2004WO2004042029A2 Oligomers comprising modified bases for binding cytosine and uracil or thymine and their use
05/21/2004WO2004042028A2 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
05/21/2004WO2004042019A2 Systems for capture and analysis of biological particles and methods using the systems
05/21/2004WO2004042016A2 Real-time pcr primers and probes for identification as ralstonia solanacearum race 3, biovar 2 in potato
05/21/2004WO2004042013A2 Identification of diet-regulated disease-associated genes
05/21/2004WO2004041924A2 Non-phosphorous-linked oligomeric compounds and their use in gene modulation
05/21/2004WO2004041889A2 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
05/21/2004WO2004041843A2 Hop - a novel cardiac-restricted transcriptional factor potentially useful for cardiac regeneration and specification
05/21/2004WO2004041840A2 Peptide-bound chromogens used for determining enzymatic activities
05/21/2004WO2004041778A2 A method for increasing synaptic growth or plasticity
05/21/2004WO2004041216A2 Ptpn11 (shp-2) mutations and cancer
05/21/2004WO2004041212A2 Apkc isoforms in nervous system disorders and cancer
05/21/2004WO2004041202A2 Analysis of pharmaceutical solubility and stability
05/21/2004WO2004041196A2 Methods and compositions for the diagnosis of neuroendocrine lung cancer
05/21/2004WO2004041193A2 HUMAN TYPE II DIABETES GENE-Kv CHANNEL-INTERACTING PROTEIN (KChIP1) LOCATED ON CHROMOSOME 5
05/21/2004WO2004041192A2 Panels of molecular targets differentially expressed during cd8+ t-cell priming
05/21/2004WO2004041177A2 Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells
05/21/2004WO2004041160A2 Methods and animal model for analyzing age-related macular degeneration
05/21/2004WO2004041115A2 Novel human elastases and stress urinary incontinence
05/21/2004WO2004041076A2 Methods of detecting colorectal cancer
05/21/2004WO2004041067A2 Prevention and treatment of synucleinopathic disease
05/21/2004WO2004041061A2 Substrates, devices, and methods for cellular assays
05/21/2004WO2004031351A9 Microarrays having multiple oligonucleotides in single array features
05/21/2004WO2004027083A3 An analyzer for the simultaneous enzymatic detection of closely related analytes
05/21/2004WO2004027020A9 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis
05/21/2004WO2004024087A9 Methods of diagnosing and treating hyperproliferative disorders
05/21/2004WO2004023092A3 Genetic analysis and authentication
05/21/2004WO2004022784A3 Strand specific detection and quantification
05/21/2004WO2004022770A9 Compositions and methods for synthesizing nucleic acids
05/21/2004WO2004022769A3 Means of detecting neurodegenerative processes and applications of same
05/21/2004WO2004022709A3 Epitope sequences
05/21/2004WO2004020675A9 Polymorphism detection among homologous sequences
05/21/2004WO2004015141A3 Method for the rapid assessment of the presence and viability of bacterial cells and use thereof________________________
05/21/2004WO2004014222A3 Diagnosis and treatment of tuberous sclerosis
05/21/2004WO2004013610A3 Method of measuring molecular interactions
05/21/2004WO2004011905A8 Quality assurance/quality control for electrospray ionization processes
05/21/2004WO2004009843A3 Detection of microorganisms
05/21/2004WO2004009759A8 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections
05/21/2004WO2004005476A3 Nucleic acid compositions for stimulating immune responses
05/21/2004WO2004001506A3 Antireflective coatings for high-resolution photolithographic synthesis of dna array
05/21/2004WO2003104426A3 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof
05/21/2004WO2003104404A8 Cancer-linked gene as target for chemotherapy
05/21/2004WO2003102215A3 Methods of identifying and isolating stem cells and cancer stem cells
05/21/2004WO2003087403A3 Diagnostic and therapeutic use of a golgi protein for neurodegenerative diseases
05/21/2004WO2003087388A9 Bioluminescence regenerative cycle (brc) for nucleic acid quantification
05/21/2004WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
05/21/2004WO2003077851A9 Compounds and methods for analyzing the proteome
05/21/2004WO2003055440A8 Compositions and methods for the treatement of immune related diseases
05/21/2004WO2003042362A8 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
05/21/2004WO2003040296A8 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
05/21/2004WO2002102306A8 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
05/21/2004WO2002096923B1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
05/21/2004WO2002081490A8 Computer-directed assembly of a polynucleotide encoding a target polypeptide
05/21/2004WO2002061105A8 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
05/21/2004WO2002036812A3 Nonlinear system identification for class prediction in bioinformatics and related applications
05/21/2004WO2002014467A8 Cng2b: a putative human cyclic nucleotide-gated ion channel
05/21/2004WO2000058340A3 50 human secreted proteins
05/21/2004CA2506654A1 Method of detecting gene mutation
05/21/2004CA2505707A1 Method of detecting bone paget's disease
05/21/2004CA2505515A1 Fret probes and methods for detecting interacting molecules
05/21/2004CA2504829A1 Diagnostic assay for measuring a cell mediated immune response
05/21/2004CA2504694A1 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
05/21/2004CA2504593A1 Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells
05/21/2004CA2504481A1 Systems for capture and analysis of biological particles and methods using the systems
05/21/2004CA2504419A1 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
05/21/2004CA2504350A1 Apkc isoforms in nervous system disorders and cancer
05/21/2004CA2503811A1 Identification of diet-regulated disease-associated genes
05/21/2004CA2503561A1 Prevention and treatment of synucleinopathic disease
05/21/2004CA2501523A1 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5
05/21/2004CA2501514A1 Human type ii diabetes gene-slit-3 located on chromosome 5q35
05/21/2004CA2486812A1 Substrates, devices, and methods for cellular assays
05/21/2004CA2484948A1 Electrical detection of dna hybridization and specific binding events
05/21/2004CA2483868A1 Compositions and methods for detection and isolation of phosphorylated molecules
05/21/2004CA2483481A1 Method for diagnosing and monitoring cardiac transplant rejection
05/20/2004US20040098769 Comprises nucleotide sequences coding single-stranded DNA-binding protein for modulating DNA replication, repair and recombination; tissue engineering
05/20/2004US20040097722 Preparation of phosphorothioate oligomers
05/20/2004US20040097708 Comprises nucleotide sequences coding membrane protein associated with odor detection for use in biological pest control
05/20/2004US20040097706 Streptococcus pyogenes antigens and corresponding dna fragments
05/20/2004US20040097704 Allelic opiate membrane protein for determining susceptibility of individuals to addictive diseases; monitoring response to analgesics and learning enhancement agents
05/20/2004US20040097460 Diagnosis of sepsis or SIRS using biomarker profiles
05/20/2004US20040097455 Cloning of reporter genes and cDNA encoding for therapeutic proteins for the treatment of hepatic, pulmonary, renal, heart, pancreas fibrosis, keloids and hypertrophic scars, in mammals, including human beings
05/20/2004US20040097452 Modulation of kallikrein 6 expression
05/20/2004US20040097451 Modulation of nidogen expression
05/20/2004US20040097450 Modulation of TDP-1 expression
05/20/2004US20040097449 Modulation of KIAA0415 expression
05/20/2004US20040097448 Modulation of CD24 expression
05/20/2004US20040097439 Useful to study, increase and/or reduce genes expression, and to improve DNA vaccination
05/20/2004US20040097428 Methods for inhibiting cancer and scar formation
05/20/2004US20040097402 Therapy for infections; bactericides; synergistic mixtures
05/20/2004US20040096975 Transgenic tolypocladium for use in generation of disease resistant plant isolates and pollution control; biological pest control
05/20/2004US20040096973 Diagnosing and preventing microorganismal infections using iron-restricted conditions; genetic vaccines
05/20/2004US20040096972 Chimeric plasmid comprising a replicative retroviral genome, and uses
05/20/2004US20040096962 Kit used for fabricating an integrated biomolecule sensor
05/20/2004US20040096960 Microchannel apparatus for use in nucleic acid sequencing, enzyme kinetics and diagnostics screening
05/20/2004US20040096958 Thermal strip thermocycler
05/20/2004US20040096956 Trangenic cells for generation of immunoglobulins for detection, quantitation, purification and neutralization of antigens; therapeutic diagnostics
05/20/2004US20040096940 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof
05/20/2004US20040096939 Modifier of organelle metabolism
05/20/2004US20040096937 Using nucleotide sequences probes to identify antibiotic resistant enterococci